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Abstract 
In this work, the NRTL-SAC and the Pharma UNIFAC models are evaluated with respect to the 
capability of prediction of solid-liquid equilibria of pharmaceutical compounds in organic 
solvents. The original NRTL-SAC model is extended through the introduction of temperature-
dependent binary interaction parameters, and the two versions of the model are parametrized using 
VLE data. The performance of the NRTL-SAC models for correlation and prediction of the 
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solubility of eight medium-sized flexible pharmaceutical or pharmaceutically similar molecules in 
multiple pure, organic solvents is examined: risperidone, fenofibrate, fenoxycarb, tolbutamide, 
meglumine, butyl paraben, butamben and salicylamide. The performance of the Pharma UNIFAC 
model is evaluated using data for six of these compounds. In general, it is found that introducing 
a dependence on temperature to the binary interaction parameters of the NRTL-SAC model can 
improve its capability for modeling and prediction of the solubility of active pharmaceutical 
ingredients. For prediction of solubility data the Pharma UNIFAC model generally performs below 
the two NRTL-SAC models. Averaged over all evaluated systems where the solubility was 
predicted with each method, the root mean squared logarithmic error in predicted mole fraction 
solubility obtained for Pharma UNIFAC (30 systems) and for the original and the modified 
temperature-dependent forms of the NRTL-SAC model (29 systems) are 1.64, 1.17 and 1.09, 
respectively. Comparing only those systems for which all models were evaluated (18 systems), the 
RMSLE values are 1.42, 1.06 and 0.87, respectively. 
Keywords: Pharmaceutical, Solubility, Activity coefficient, Temperature, NRTL-SAC, Pharma 
UNIFAC 
 
 
 
Introduction 
Experimental determination of solid-liquid solubility can be a costly and tedious process, and 
accurate methods for prediction are in high demand. The basis for the vast majority of solubility 
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models is the separation of the ideal component, the activity of the solute, which at equilibrium is 
equal to the activity of the pure solid, as, from the activity coefficient in the saturated solution, γsat. 
In logarithmic notation: 
sat
s
sat lnlnln  ax          (1) 
where xsat denotes mole fraction solubility. Within a Raoult’s law framework, the activity of the 
pure solid is most conveniently defined with the pure liquid phase at the same temperature, in 
effect a supercooled melt, as the thermodynamic reference state.1 Thus, for an ideal solution the 
activity coefficient equals unity and the solubility equals the activity of the solid. 
For accurate prediction of the mole fraction solubility, it is necessary to estimate both the activity 
of the solid phase and the activity coefficient in the saturated solution. The activity of the pure 
solid can be expressed as:2
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where ∆fusH (Tm) denotes the heat of fusion at the melting point, R the universal gas constant, and 
∆Cp the difference in heat capacity between the supercooled melt and the solid. The heat capacity 
terms in eq 2 are often neglected, but it has been shown in several studies3-6 that this practice can 
lead to a substantial error, at least for molecules with conformational flexibility and relatively high 
melting points, such as most pharmaceuticals. 
Numerous models for the correlation and prediction of solution activity coefficients within a 
Raoult’s law framework have been proposed in the literature. These can be divided into three 
classes: correlative models including the Wilson,7 UNIQUAC8 and NRTL9 models; predictive 
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models such as UNIFAC10 and its modifications, COSMO-RS11 and COSMO-SAC;12 and semi-
predictive models like NRTL-SAC.13 So far, no model has been shown to be capable of predicting 
the solubility of pharmaceutical compounds with an accuracy sufficient for process design, i.e. at 
least in the order of ± 15% for calculations of yield and productivity, and – because crystallization 
kinetics depend strongly on the supersaturation – in the order of ± 1% for estimation of 
crystallization driving forces and prediction of product crystal size distributions. 
Correlative models are chiefly fitted to experimental data for the determination of a parameter set 
to be used for a given system. Mirmehrabi et al.14 used a group contribution method to obtain 
parameters associated with UNIQUAC and utilized two adjustable parameters to model solubility 
data of two polymorphs of ranitidine hydrochloride. The average relative deviation (ARD) error 
of solubility correlation in their work was reported to be between 0.89% – 3.53% for two forms of 
ranitidine hydrochloride in different solvents. The NRTL model, using two adjustable 
parameters,15 has been used to correlate the solubility of niflumic acid, flufenamic acid and 
diclofenac sodium in different solvents. The authors report deviations between correlated and 
experimental temperature to be in range 1 – 3 K, which corresponds to an ARD of approx. 2% in 
solubility. 
For the attempted prediction of the solubility of drugs, the COSMO-RS and COSMO-SAC models 
have been used extensively. Mullins et al.16 report root mean squared logarithmic errors (RMSLE) 
in mole fraction solubility ranging between 1.6 and 3.26 for these methods. However, they suffer 
from being computationally expensive. As regards the UNIFAC model, a limitation of the original 
model when considering pharmaceuticals is the fact that parameters for certain functional groups 
and binary interactions are missing. Diedrichs and Gmehling17 evaluated a modification, Pharma 
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UNIFAC, specially developed for the prediction of solubilities of active pharmaceutical 
ingredients (APIs). They found that this model exhibited an improved capability for modeling 
pharmaceutical compounds compared to other predictive models. For a set of APIs in different 
solvents, they report RMSLE values of predicted solubilities in the range 1.0 – 2.6 for Pharma 
UNIFAC, 1.2 – 2.8 for COSMO-SAC, and 1.1 – 2.6 for NRTL-SAC.  
The PC-SAFT18 Equation of State (EoS) is an example of a new class of semi-predictive models, 
which rely on parameters determined using a limited set of experimental data, based on which the 
solubility in other solvents can then be predicted. Ruther and Sadowski19 applied the PC-SAFT 
EoS for the prediction and correlation of solubility of pharmaceuticals, fitting four adjustable 
parameters to solubility data in a single solvent, and predicting the solubility in other solvents, 
with reportedly acceptable results. The same model was also evaluated by Spyriouni et al.20, fitting 
parameters to data in three solvents and predicting the solubility in other solvents, with reported 
RMSLE values in log x between 0.27 and 0.48. 
The semi-predictive activity coefficient model NRTL-SAC was introduced in 2004 by Chen and 
Song.13 Mota et al.21 used this model for the estimation of the solubility of a set of pharmaceutical 
compounds, fitting the model parameters to data in four organic solvents, and predicting the 
solubility in aqueous solutions with a reported average relative error of 38% in mole fraction 
solubility. Compared to the aimed-for accuracy this is by no means remarkable. However, 
comparisons of this model with other thermodynamic models has shown its relative advantage in 
robustness and accuracy; Tung et al.22 compared the performances of NRTL-SAC and COSMO-
SAC for the prediction of solubility in thirteen common solvents of the drugs lovastatin, 
simvastatin, rofecoxib and etoricoxib, demonstrating the better performance of NRTL-SAC, with 
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RMSLE in log x in the range 0.03 – 0.1 compared to 0.12 – 0.31 for COSMO-SAC. 
Sheikholeslamzadeh and Rohani23 compared NRTL-SAC and UNIFAC for the calculation of 
solubility of 3-pentadecylphenol, lovastatin and valsartan in different solvents, likewise 
concluding that the former model gives better results. These authors used three sets of calibration 
solvents to fit parameters, obtaining an ARD of 21% for the “best” NRTL-SAC method compared 
to 64% for UNIFAC. In 2015, Haghtalab and Yousefi Seyf presented a related segment-based 
model, building on the Universal Quasichemical approach, called UNIQUAC-SAC.24 Using a 
slightly different dataset for their parametrization, the authors found this model to perform with 
higher accuracy and consistency than the NRTL-SAC model for prediction of multicomponent 
VLE systems as well as the solubility of a set of pharmaceutical molecules. 
Unlike many other activity coefficient models (such as UNIQUAC-SAC24) the interaction energy 
parameters of the original NRTL-SAC model lack a defined temperature-dependence. In effect, 
this means that the temperature-dependence of the activity coefficient in saturated solution is 
ignored, and only the influence of temperature on the activity of the solid is accounted for, e.g. 
through Eq. 2. One aim of the present study is to introduce a simple dependence on temperature to 
the interaction parameters, and evaluate potential improvements in predicting solid-liquid 
equilibria. A secondary aim is to compare the prediction capability of the original and the modified 
NRTL-SAC models with that of a purely predictive method, Pharma UNIFAC. The models have 
been evaluated against experimental solubility data at multiple temperatures of a set of organic, 
crystalline compounds in different, pure solvents, totaling 45 binary systems. The molecules are 
either pharmaceuticals or of a size and complexity typical of pharmaceuticals.  
Modeling work 
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Pharmaceutical model compounds 
The eight model compounds used in this evaluation are shown in Figure 1. All are medium-sized 
organic molecules with some conformational flexibility and with polar, non-polar and hydrogen-
bonding functionality. Furthermore, all are either pharmaceutical compounds or chemically 
similar. For all these compounds, melting points, heats of fusion and heat capacities of both the 
solid and the supercooled melt have previously been experimentally determined. This allows the 
activity of the pure solid (eq 2), and thereby the activity coefficients at saturation (eq 1), to be 
determined with comparatively high accuracy. 
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Figure 1. The model compounds.  
Calorimetric data are given in Table 1. In case the compound has several known polymorphs, data 
for the stable form has been used. For the enantiotropic compound tolbutamide, the high-
temperature form was used. For data determined within our group, 95% confidence intervals are 
specified. For salicylamide, the tabulated heat capacity coefficients are based on data determined 
in-house according to the same procedure as for the other compounds. Details are given in the 
9 
 
supporting information. The data for butamben has not yet been published. In all cases, ΔCp is well 
correlated by a linear equation of two parameters, A and B: 
)( TTBAC mp           (3) 
Table 1. Reported melting points and associated heats of fusion together with 95% confidence 
intervals and coefficients of Eq. (3) for the eight model compounds. 
Compound Tm  
/ K 
ΔfusH(Tm)  
/ kJ mol-1 
A  
/ J K-1 mol-1 
B  
/ J K-2 mol-1 
References  
Risperidone 442.4±0.3 43.9±0.2 158.1 0.5214 25 
Fenofibrate 352.05±0.02 33.5±0.5 124.3 0.5192 26 
Fenoxycarb 326.3 26.98 106.5 0.0424 27, 28 
Tolbutamide 390 28.3 100.4 0.5102 29, 30 
Meglumine 400.9±0.2 51±1.0 237.2 0.7240 31 
Butyl paraben 340.5±0.4 26±1.4 77.2 0.4900 32 
Butamben 330.56±0.02 24.7±0.6 29.8 0.8371  
Salicylamide 411.9±0.5 29.0±0.3 60.2  0.2872 33 
The NRTL-SAC model 
In the NRTL-SAC model a solution is treated as a mixture of molecular segments. Each molecule 
is described in terms of four different conceptual segments, and segment-segment binary 
interaction parameters are introduced. The four segments are labelled as follows: X for the 
hydrophobic, Y- for the polar attractive, Y+ for the polar repulsive, and Z for the hydrophilic 
segment. The hydrophobic segment represents the molecular surface area which is unlikely to form 
hydrogen bonds, the hydrophilic segment represents the area with interactions likely to form 
hydrogen bonds, and the polar segment represents the area with interactions characteristic of an 
electron donor or acceptor. For each pair of different segments i and j, there are two dimensionless 
binary interaction parameters, denoted ij and ji , and the amount of a segment in a molecule is 
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given by a parameter called the segment number, rm,I, for segment type m in molecule I. In the 
original NRTL model,9 τij is related to the segment interaction energy as τij = Δgij / RT. 
The activity coefficient is the sum of two terms, the combinatorial and residual contributions: 
R
I
C
II  lnlnln            (4) 
The combinatorial term, adapted from Flory-Huggins theory, is entropic in nature and accounts 
for differences in molecular size. The residual term is enthalpic in nature, and results from the 
energetic interactions between the components of a mixture. The residual term is expressed as: 
 ,,ln ln lnR lc lc II m I m m
m
r            (5) 
Гmlc denotes the (local composition) activity coefficient of segment m, and Гmlc,I the activity 
coefficient of segment m within component I. The two terms can be expressed as: 
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 expij ijG            (8) 
The complete set of equations pertaining to the NRTL-SAC model is reported by Chen and Song.13 
In the above equations r denotes segment numbers, and α is the NRTL non-random parameter. 
The value of α in this work is set to 0.3 for Z/Y+ and Z/Y- interactions, and 0.2 for X/Y+ , X/Y- 
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and X/Z interactions, as in the original publication.13 The indices j, k, m and m/ each refer to 
summation over the four segment types (X, Y+, Y- and Z). xj and xj,I are segment-based mole 
fractions of segment j, in total and within component I, which are functions of segment numbers 
and solution composition.  
In its original form, the NRTL-SAC model assumes segment interaction parameters τ and segment 
numbers r to be independent of temperature. However, for the NRTL model9, 34 it is well-known 
that the interaction parameters have to be given a temperature-dependence in order to be able to 
describe equilibria covering any significant temperature range. In this work, an extended NRTL-
SAC model has been evaluated, in which the interaction energy parameters are given a simple 
inverse dependence on the absolute temperature according to: 
i j
i j
b
RT
            (9) 
where bij is a temperature-independent parameter representing the interaction energy between 
segments i and j. There are 12 possible binary, direction-dependent interaction parameters between 
different segment types, to be determined using binary VLE equilibrium data for a small number 
of reference solvents: in this work, like in the original publication,13 n-hexane, water and 
acetonitrile. However, the following assumptions are made: 
y z y z
    ,   zyzy  ,   xyxy  ,
xyxy 
 and 0  yyyy   (for the original, temperature-independent NRTL-SAC model) and 
zyzy
bb   ,   zyzy bb ,   xyxy bb , xyxy bb   and 0  yyyy bb  (for the temperature-dependent 
NRTL-SAC model.) This leaves 6 interaction parameters to be determined using data for the 
reference solvents. For each solvent for which the model is to be used (solvent as distinguished 
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from reference solvent) there are four segment numbers that have to be determined using binary 
equilibrium data between the particular solvent and each of the reference solvents. For each solute 
there are also four segment numbers that are determined using solid-liquid solubility data in a 
selected number of solvents and/or reference solvents.  
In order to allow a comparison between the two functional forms of the NRTL-SAC model to be 
made, the parameters of both the original and the temperature-dependent models have been 
determined using the same data. Throughout this work, the two versions of the model together 
with the parameters determined here are referred to as NRTL-SAC(O) and NRTL-SAC(T), 
respectively. The objective function used for fitting binary interaction parameters and segment 
numbers of both NRTL-SAC models is: 
 
22
1
modelexp


C N
OF          (10) 
where γexp is the experimentally determined activity coefficient, γmodel is the activity coefficient 
calculated using NRTL-SAC, N is the number of data points and C is the component. 
The first step in parametrizing the two models involves determining binary interaction parameters 
from data of binary mixtures of the three reference solvents. Between segments X and Z: xz and 
zx were determined by fitting to the binary VLE data
35 of n-hexane – water, a mixture only 
containing X and Z segments. Building on this, the binary interaction parameters between 
segments Z, Y- and Y+: ,
zy zy
   , ,
Z Zy y
   (and  zyzy bb , , zyzy bb  , ) were determined by fitting to 
binary VLE data35 for the system acetonitrile – water which contains only X, Y- and Y+ segments 
for acetonitrile and the Z segment for water. As no VLE data are available for the system 
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acetonitrile – n-hexane, binary interaction parameters between segments X and Y- and Y+: ,
xy xy
  
, ,
y x y x
   , have been set to the same values as in the original NRTL-SAC publication13 where LLE 
data for the system acetonitrile – n-hexane was used. For NRTL-SAC(T), the temperature-
independent interaction parameters between segments X and Y-, and between X and Y+: ,
xy xy
b b 
, ,
y x y x
b b   have been obtained using: 
298ln314.8lnlnln )K298(  ijijb         (11) 
where τij(298 K) denotes the binary interaction parameter at 298 K reported in the original NRTL-
SAC publication.13  
In the second step, segment numbers for the 8 solvents used for the solid-liquid equilibria: 1-
butanol, 1-propanol, 2-propanol, acetone, ethanol, ethyl acetate, methanol and toluene, have been 
determined for both NRTL-SAC models, using VLE data taken from the DECHEMA vapor-liquid 
data collection.35 Data for 24 binary mixtures in total has been used, with each system consisting 
of a solvent and one of the three reference solvents. Segment numbers for the three reference 
solvents were taken from the original NRTL-SAC publication.13  
Experimental activity coefficient values used in the parametrization process were obtained using 
eq 12, by assuming ideal vapor phase behavior and calculating pure component vapor pressures 
with the Antoine equation.  
sat
exp
II
I
I
Px
Py
           (12) 
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Finally, in the third step, segment numbers for the eight pharmaceutical solutes have been 
determined through correlation of experimental solubility data in two different solvents for each 
compound. For this purpose, the activity of the pure solid (stable polymorph) was obtained using 
eq 2, with ∆Cp modeled by eq 3. Activity coefficients could then be calculated from experimentally 
reported solubilities (of the stable polymorph) using eq 1.  
For the parameter determination for each solute, one polar solvent (methanol) and one non-polar 
solvent (toluene, or lacking solubility data, the least polar solvent available) were selected in order 
to capture polarity-related characteristics of the solutes. Ideally, of course, three or four solvents 
rather than two should be chosen for parameter determination – selected to capture hydrophilic, 
polar attractive and repulsive, and hydrophobic interactions. However, in many such would-be 
suitable solvents the solubility is poor, and thus has not been of general interest. Consequently, 
due to a lack of experimentally available solubility data for the solute compounds, it was not 
possible to find suitable data in more solvents. Reported experimental solubility data in methanol 
and toluene was used for risperidone,25 fenoxycarb,27 tolbutamide30 and butamben (unpublished 
work), while solubility data in methanol and ethyl acetate was used for fenofibrate,26 butyl 
paraben36 and salicylamide,33 and solubility data in methanol and 2-propanol was used for 
meglumine.31 Temperature ranges are given in Table 5.  
Table 2 shows the binary interaction parameters between segments obtained for the two NRTL-
SAC models. The binary interaction parameters between segments Y- and Y+ were set to zero as 
in the original model.13 Segment numbers (rX, rY-, rY+ and rZ) for each of the solvents and solutes 
are listed in Table 3.  
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Table 2. Binary interaction parameters for the two NRTL-SAC models. 
τ xz τ zx τ y+z τ y-z, τ zy-, τ zy+ τ xy-, τ xy+ τ y-x, τ y+x 
4.7334 0.1692 1.6884 -1.6884 1.7239 1.6430 1.8340 
b xz b zx b y+z b y-z, b zy-, b zy+ b xy-, b xy+ b y-x, b y+x 
9795.42 4902.83 4247.45 -4247.45 4576.13 4070.65 4543.86 
 
Table 3. Segment numbers of solvents and solutes for the two NRTL-SAC models. 
 NRTL-SAC(O) NRTL-SAC(T) 
Compound rX rY- rY+ rZ rX rY- rY+ rZ 
Solvents         
Water 0.0000 0.0000 0.0000 1.0000 0.0000 0.0000 0.0000 1.0000 
n-Hexane 1.0000 0.0000 0.0000 0.0000 1.0000 0.0000 0.0000 0.0000 
Acetonitrile 0.0180 0.1310 0.8830 0.0000 0.0180 0.1310 0.8830 0.0000 
Methanol 
 
0.0008 0.7510 0.0000 0.0436 0.0004 0.0636 0.0006 0.5325 
Ethanol 
 
0.5784 0.0003 0.0002 0.8263 0.4466 0.0495 0.0008 0.9413 
1-Propanol 
 
1.5663 0.7220 0.0007 2.1213 0.1681 0.0003 0.0056 0.8963 
2-Propanol 
 
0.1411 0.1430 0.0000 0.4935 1.3719 0.4942 0.0145 0.0006 
1-Butanol 
 
1.1046 0.0012 1.9997 0.0001 0.9989 0.3818 1.6263 0.0019 
Acetone 
 
0.2852 0.0001 0.7782 0.0000 0.2661 0.1050 0.7000 0.0000 
Ethyl acetate 
 
1.0497 0.0003 1.5677 0.0004 0.7654 0.0949 1.1151 0.0005 
Toluene 
 
1.0306 0.0250 0.5431 0.0005 1.0631 0.0003 0.4224 0.0000 
 
F 
 
 
 
Solutes         
Risperidone  1.6800 0.1408 0.1410 0.6545 1.9122 1.7661 1.3204 0.4286 
Fenofibrate 2.0107 0.1023 0.2713 0.1860 1.6541 0.0552 1.3544 0.0099 
Fenoxycarb 1.8467 0.2535 0.0681 0.3523 1.4205 0.0552 1.2733 0.1240 
Tolbutamide 1.4993 0.3706 0.0071 0.8450 0.0052 0.1685 1.7140 0.4284 
Meglumine 0.7389 0.0000 0.9867 0.0000 0.1216 0.4170 1.5968 0.4527 
Butyl paraben 1.5274 0.8668 1.0698 0.0010 0.0101 0.0007 0.0001 0.2950 
Butamben 0.9021 0.5219 0.0559 0.2461 0.7199 0.0974 0.9951 0.2806 
Salicylamide 1.4101 0.0909 0.6025 0.1655 0.2123 0.0115 0.2756 0.2344 
Pharma UNIFAC 
In the Pharma UNIFAC model, a solution is considered as a mixture of functional groups rather 
than a mixture of molecules. The model is derived from the Modified UNIFAC (Do)37 model 
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through the introduction of additional functional groups and binary interaction parameters relevant 
for pharmaceutical molecules. Equations for the Pharma UNIFAC model are reported by Diedrichs 
and Gmehling.17 There are three sets of parameters: binary interaction parameters between each 
pair of functional groups, and two parameters Rk and Qk for each functional group. In the UNIFAC 
terminology, the functional groups for meglumine are: 1 × CH3, 4 × CHOH, 1 × CH2OH, and 1 × 
CH2NH, for salicylamide: 4 × ACH, 1 × ACOH, and 1 × AC-CONH2, for butamben: 1 × ACNH2, 
4 × ACH, 1 × ACCOO, 3 × CH2, and 1 × CH3, for butyl paraben: 1 × CH3, 3 × CH2, 4 × ACH, 1 
× ACOH, and 1 × ACCO, for tolbutamide: 2 × CH3, 3 × CH2, 1 × NHCONH, 1 × SO2, and 4 × 
ACH and for fenoxycarb: 1 × CH3, 2 × CH2, 1 × COO, 1 × CH2NH, 2 × ACO, 9 × ACH, and 1 × 
C. Fenofibrate and risperidone were excluded since parameters are not available for all the 
functional groups of these molecules. Mole fraction solubilities of solute – solvent systems have 
been calculated iteratively using eq 1 since the activity coefficient depends on concentration. Initial 
estimates were set to the experimentally reported values.  
Results and discussion 
Comparison of functional forms of the NRTL-SAC model for correlation of VLE data 
The difference between experimental activity coefficients and activity coefficients, calculated with 
the two respective NRTL-SAC models for each component of 26 binary mixtures using the 
parameters given in Tables 2 and 3, has been quantified using the average relative deviation, 
defined as: 



N I
II
N
ARD
exp
modelexp
1


        (13) 
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where I denotes component and N the number of data points. The results are presented in Table 4.  
Although there are individual cases in Table 4 where NRTL-SAC(O) results in a lower ARD than 
the temperature-dependent model, the overall average ARD, taken over all γ1 + γ2 values in Table 
4, is lower for NRTL-SAC(T) (0.16) than for NRTL-SAC(O) (0.19).  
 
Figure 2. ARD in correlated activity coefficients vs. experimental values for the two NRTL-SAC 
models. Each point represents the average ARD for both components in binary systems of one 
organic solvent in each of the reference solvents: n-hexane, acetonitrile and water.  
Considering each of the solvents in binary mixtures with each of the three reference solvents, as 
in the determination of the segment parameters, and averaging the ARD of γ1 + γ2 over three binary 
systems for each solvent, results in values plotted in Figure 2. The introduction of a temperature-
dependent binary interaction parameter improves the performance of the NRTL-SAC model for 
all the solvents, with the exception of 2-propanol for which the ARD is unchanged. Overall, it can 
be stated with certainty that the introduction of a temperature-dependent binary interaction 
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parameter to this model leads to a measurable, although modest, improvement in the correlation 
of VLE data. 
Table 4. Average relative deviation (ARD) in activity coefficients for the two NRTL-SAC models. 
   T-range 
ARD 
NRTL-SAC(O) NRTL-SAC(T) 
Component 1 Component 2 N (K) 
 
γ1 γ2 γ1 γ2 
Water n-Hexane 17 363 - 473 0.18 0.06 0.15 
 
0.06 
 
Acetonitrile Water 11 353 - 359  0.06 
 
0.11 
 
0.04 
 
0.11 
 Methanol 
n-Hexane 7 329 - 333 0.06 
 
0.05 
 
0.08 
 
0.08 
 
Acetonitrile 21 314 - 323 0.24 
 
0.22 
 
0.07 
 
0.09 
 
Water 8 339 - 369 0.57 
 
0.17 
 
0.46 
 
0.11 
 Ethanol 
n-Hexane 16 339 - 349 0.25 
 
0.20 
 
0.16 
 
0.12 
 
Acetonitrile 3 293 - 323 0.66 
 
0.27 
 
0.44 
 
0.22 
 
Water 12 351 - 369 0.29 
 
0.27 
 
0.25 
 
0.23 
 1-Propanol 
n-Hexane 16 336 - 350 0.30 
 
0.60 0.24 
 
0.37 
 
Acetonitrile 17 354 - 363 0.17 
 
0.17 
 
0.22 
 
0.22 
 
Water 15 367 - 371 0.21 
 
0.10 
 
0.23 
 
0.06 
 2-Propanol 
n-Hexane 14 337 - 350 0.10 
 
0.09 
 
0.44 
 
0.31 
 
Acetonitrile 15 351 - 354 0.23 
 
0.22 
 
0.27 
 
0.33 
 
Water 26 354 - 372 0.39 
 
0.33 
 
0.04 
 
0.03 
 1-Butanol 
n-Hexane 20 
1111
1 
 
341 - 380  0.09 
 
0.11 
 
0.11 
 
0.09 
 
Acetonitrile 14 354 - 390 0.26 
 
0.41 
 
0.28 
 
0.43 
 
Water 28 372 - 384 0.25 
 
0.12 
 
0.03 
 
0.03 
 Acetone 
n-Hexane 9 324 - 332 0.03 
 
0.01 
 
0.02 
 
0.02 
 
Acetonitrile 9 330 - 352 0.11 
 
0.04 
 
0.08 
 
0.03 
 
Water 12 331 - 368 0.10 
 
0.06 
 
0.06 
 
0.06 
 Ethyl acetate 
n-Hexane 3 353 - 355 0.02 
 
0.12 
 
0.06 
 
0.04 
 
Acetonitrile 4 333 - 353 0.03 
 
0.01 
 
0.03 
 
0.01 
 
Water 5 343 - 380 0.02 
 
0.02 
 
0.02 
 
0.01 
 Toluene 
n-Hexane 5 293 - 313 0.70 
 
0.11 
 
0.72 
 
0.14 
 
Acetonitrile 25 354 - 381 0.25 
 
0.19 
 
0.25 
 
0.12 
 
Water 14 342 - 363 0.24 
 
0.21 
 
0.22 
 
0.16 
 
Overall     0.19 0.16 
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Comparison of all three models for prediction of solid-liquid solubility 
In Table 5 the root mean squared logarithmic error (RMSLE) in calculated vs. experimental mole 
fraction solubility, eq 14, for each of the solute – solvent systems are listed for each of the evaluated 
methods. Solvents used for parameter determination, and for which, consequently, the listed errors 
refer to data correlation rather than prediction, are marked with an asterisk (*). 
  
N
xx
N
RMSLE
2modelexp lnln
1
       (14) 
In Figure 3, for each system, RMSLE values obtained with NRTL-SAC(T) and Pharma UNIFAC 
are plotted vs. values obtained with NRTL-SAC(O). There are fewer data points in the graph 
representing Pharma UNIFAC as this model could only be evaluated for six out of eight 
compounds.  
 
Figure 3. RMSLE in mole fraction solubilities predicted with NRTL-SAC(T) and Pharma 
UNIFAC vs. the corresponding values obtained for NRTL-SAC(O), for the systems in Table 5. 
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Table 5. RMSLE in predicted mole fraction solubility for the three models. An asterisk (*) 
indicates that the solvent was used in the parameter determination. 
    RMSLE 
Compound Solvent N T-range 
(K) 
Pharma 
UNIFAC 
NRTL-SAC(O) NRTL-SAC(T) 
Risperidone Methanol* 10 278 - 323  0.22 0.08 
Toluene* 10 278 - 323  0.16 
 
0.14 
 Ethanol 10 278 - 323  2.30 
 
1.22 
 1-Propanol 10 278 - 323  1.70 
 
2.39 
 2-Propanol 10 278 - 323  2.85 
 
1.87 
 1-Butanol 10 278 - 323  1.67 
 
1.47 
 Acetone 10 278 - 323  0.41 
 
4.03 
 Ethyl acetate 10 278 - 323  0.39 
 
2.14 
 Fenofibrate Methanol* 5 278 - 318  0.13 
 
0.04 
 
Ethyl acetate* 5 278 - 318  0.92 
 
0.12 
 Ethanol 5 278 - 318  1.71 
 
0.59 
 1-Propanol 5 278 - 318  1.37 
 
1.43 
 2-Propanol 6 278 - 318  2.79 
 
2.97 
 Acetonitrile 5 278 - 318  0.30 
 
1.39 
 Acetone 5 278 - 318  1.02 
 
0.15 
 Fenoxycarb Methanol* 9 278 - 318 1.35 0.09 0.02 
Toluene* 6 278 - 318 0.50 0.20 0.17 
Ethanol 9 278 - 318 0.92 1.21 0.45 
2-Propanol 9 278 - 318 1.53 1.72 1.61 
Ethyl acetate 6 278 - 318 1.14 0.96 0.02 
Tolbutamide Methanol* 9 278 - 313 2.00 0.12 0.21 
Toluene* 9 278 - 313 4.89 1.59 0.52 
Acetonitrile 9 278 - 313 0.85 2.17 1.79 
Ethyl acetate 9 278 - 313 1.88 1.25 0.06 
1-Propanol 9 278 - 313 2.68 1.39 1.06 
Meglumine Methanol* 5 283 - 323 3.83 0.33 0.63 
2-Propanol* 5 283 - 323 0.83 1.47 0.26 
Ethanol 5 283 - 323 1.56 0.44 1.05 
1-Propanol 5 283 - 323 1.01 1.13 0.53 
Butyl 
paraben 
Methanol* 5 283 - 323 0.18 0.13 0.02 
Ethyl acetate* 5 283 - 323 0.91 0.25 0.05 
Ethanol 5 283 - 323 0.12 0.09 0.20 
1-Propanol 5 283 - 323 0.49 0.79 0.09 
Acetonitrile 5 283 - 323 0.19 0.27 0.50 
Acetone 5 283 - 323 0.18 0.14 0.03 
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Butamben 
 
 
Methanol* 4 283 - 298 4.31 0.02 0.02 
Toluene* 4 283 - 298 0.71 0.02 0.04 
1-Propanol 4 283 - 298 2.59 0.70 0.59 
2-Propanol 4 283 - 298 2.54 0.59 0.34 
1-Butanol 4 283 - 298 1.39 0.09 0.62 
Salicylamide Methanol* 9 283 - 323 1.30 0.03 0.01 
Ethyl acetate* 9 283 - 323 2.36 0.03 0.08 
Acetonitrile 9 283 - 323 0.39 0.68 0.96 
Acetone 9 283 - 323 2.04 0.46 0.15 
Water 9 283 - 323 2.99 4.50 5.12 
 
As can be seen in Figure 3 and Table 5, overall the NRTL-SAC models perform better than Pharma 
UNIFAC. In only 5 out of 30 systems where all three models could be evaluated Pharma UNIFAC 
results in the lowest prediction error. Out of the remaining 25 systems (13 of which constitute 
predictions rather than correlations for the NRTL-SAC models) one (5 cases) or both (20 cases) 
of the NRTL-SAC models perform better than Pharma UNIFAC. Averaged over all solvents, for 
each compound either of the NRTL-SAC models results in the lowest overall error.  
All methods perform best overall for butyl paraben, and this is also the compound for which the 
Pharma UNIFAC method comes closest in performance relative to the two NRTL-SAC models. 
For solubility prediction of this compound, each method performs better than the others in at least 
one solvent each. In Figure 4, the experimental solubility of butyl paraben in four solvents is 
compared with solubility curves predicted using the three models. In acetonitrile, the Pharma 
UNIFAC model leads to better results in terms of relative error than both of the NRTL-SAC 
models, but looking at Figure 4 a it can be seen that in terms of absolute fits the three models are 
approximately equal. In the other solvents at least one of the NRTL-SAC models results in a more 
accurate prediction than the Pharma UNIFAC model. Particularly notable is the very high 
prediction accuracy (RMSLE 0.03) obtained with NRTL-SAC(T) in acetone. 
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Figure 4. Predicted and experimentally determined solubility curves of butyl paraben in different 
solvents; a) acetonitrile; b) ethanol; c) acetone; d) 1-propanol. 
As regards the comparison between the two NRTL-SAC models, for correlation of data in the 
solvents used for parameter determination (2 solvents per solute, 16 systems in total), the average 
RMSLE values obtained with NRTL-SAC(T) and NRTL-SAC(O) are 0.15 and 0.36, respectively. 
For prediction of solubility in the remaining solvents for all the compounds (29 systems in total) 
the total averaged RMSLE of the two models are more similar: 1.09 and 1.17, respectively. The 
corresponding average for the Pharma UNIFAC model is 1.42, but this model could only be 
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evaluated for 6 compounds; the average RMSLE values over these 6 compounds obtained with 
NRTL-SAC(T) and NRTL-SAC(O) are 0.87 and 1.06, respectively. 
The range of observed RMSLE errors is quite substantial; for Pharma UNIFAC it is between 0.12 
(butyl paraben in ethanol) and 4.89 (tolbutamide in toluene). For the two NRTL-SAC methods, 
there are several cases of very small errors (<0.05) while the maximum errors for both methods 
are obtained for salicylamide in water (5.12 and 4.50, respectively). There are some striking cases 
of large differences in errors obtained with the two NRTL-SAC methods in the same system; for 
risperidone in acetone, the error obtained with the temperature-dependent model (4.03) is an order 
of magnitude larger than that obtained with the original model (0.41). Examples of the opposite 
behavior are fenoxycarb in ethyl acetate (0.02 vs. 0.96), and tolbutamide in ethyl acetate (0.06 vs. 
1.25). There are no apparent systematic differences between the functional forms of the NRTL-
SAC method with respect to the range of errors observed, however, with differences on the level 
of individual systems apparently random occurrences. 
It should be noted in this context that the RMSLE errors are similar in magnitude as the expected 
size of the contribution to the activity from the heat capacity terms in eq 2 for pharmaceutical 
molecules. For the compounds in this work, the activity of the solid (ideal solubility), and thus the 
activity coefficient in all solvents, was found to decrease by between 3% - 86% (36% on average 
over all 8 compounds) when disregarding the contribution from ∆Cp. This corresponds to an 
RMSLE value of 0.93 calculated over all 8 compounds. This points to the importance of not 
neglecting the heat capacity in the modelling of the activity of the solid when predicting solubility.  
Looking at all the systems in Table 5, the temperature-dependent model scores better in 29 out of 
45 cases, including all fenoxycarb systems. In Figure 3, with the notable exception of one outlier 
24 
 
(risperidone in acetone), there is a visible trend of data points comparing the two NRTL-SAC 
methods being shifted to the right of the diagonal. Overall, this shows that, as a general expectation, 
the introduction of a simple inverse temperature-dependence to the binary interaction parameters 
of the NRTL-SAC model does lead to a modestly improved accuracy in the prediction of the 
solubility of pharmaceutical compounds. 
The worst prediction results overall were obtained for risperidone. This molecule is arguably the 
most complex one out of the eight pharmaceutical compounds evaluated. Conversely, butyl 
paraben and butamben, two much less complex molecules, resulted in the overall best predictions. 
The simplest indicator of the complexity of a molecule is its molecular weight. Figure 5 shows a 
breakdown of RMSLE values for each compound, averaged over all the solvents (a) as well as for 
only the solvents where actual prediction was performed for the NRTL-SAC models (b), for the 
three evaluated models. As can be seen in Figure 5 b, for the NRTL-SAC models there is a 
tendency towards increased prediction error for substances with increasing molecular weight. 
Salicylamide, the only compound for which the solubility in water was included in the evaluation, 
constitutes a clear exception to this trend. It is notable that the prediction results for this compound 
in aqueous solution are significantly worse than in the organic solvents, for all the models. Indeed, 
for the NRTL-SAC models, the results for salicylamide in water are the worst out of all evaluated 
systems. In Figure 5, the second set of bars shown for salicylamide includes only the organic 
solvents. If water is disregarded, the prediction results for salicylamide become much better, and 
for the NRTL-SAC models significantly more in line with the trend observed for the other 
compounds. No apparent difference in prediction accuracy is seen among the organic solvents. 
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Figure 5. RMSLE of solubilities obtained using the three models, shown for each compound in 
order of increasing molecular weight; averaged over a) all solvents, and b) excluding solvents used 
for parametrization of the NRTL-SAC models.  
In Figure 6, the RMSLE values in Figure 5 b obtained with the temperature-dependent NRTL-
SAC model are plotted vs. solute molecular weight. For salicylamide, only organic solvents are 
included. Figure 6 shows clearly the trend of increasing prediction error with increasing molecular 
weight. Overall, Figures 5 and 6 indicate that – for the NRTL-SAC methods – the underlying 
assumptions work best for small compounds, and in organic solvents. For Pharma UNIFAC we do 
not see the same trend, which is logical since this method inherently accommodates an increased 
molecular complexity through the addition of functional groups to the representation of the 
molecule. 
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Figure 6. RMSLE of solubilities predicted with NRTL-SAC(T) averaged over different solvents 
for each compound vs. molecular weight. For salicylamide, only organic solvents were included. 
Within the framework of group contribution methods, the accuracy of the Pharma UNIFAC model 
depends on the determination of binary interaction parameters. These have been determined from 
correlations to large amounts of VLE and SLE data. Diedrichs and Gmehling17 have shown that 
the Pharma UNIFAC model can outperform the original UNIFAC and the Modified UNIFAC (Do) 
models, but the results of this work indicate that there remains a need for further development of 
the UNIFAC models in order to enable prediction of the solubility of pharmaceuticals with 
acceptable accuracy. It should be kept in mind, however, that an important strength of the Pharma 
UNIFAC model is that basically no data needs to be experimentally determined for the particular 
compound. As regards the NRTL-SAC models, the prediction accuracy depends on the activity 
coefficient data used to calibrate the respective model. In this work, due to a lack of solubility data 
in sufficient numbers of chemically diverse solvents, we used only two solvents to determine 
segment numbers of the model pharmaceuticals. As such, the results obtained with these methods 
are suboptimal. Although even with this limitation both NRTL-SAC models did perform better 
overall than Pharma UNIFAC, we do expect the introduction of additional solvents for 
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parametrization to improve the prediction capability. For the purpose of verifying this statement 
for one case, we have re-determined segment parameters of NRTL-SAC(T) for one of the 
compounds, salicylamide, but this time using data in four solvents (methanol, ethyl acetate, 
acetone and acetonitrile). Using the new segment parameters: rX = 0.610, rY- = 0.048, rY+ = 1.064 
and rZ = 0.534, the RMSLE in predicted solubility in water was in fact significantly reduced, from 
5.12 to 3.44.  
On a final note, as a general hypothesis, we expect the significance of the temperature-dependence 
of the interaction parameters to be larger the wider the range of temperatures to be covered. 
However, there is no apparent trend in relative performance between the models with increasing 
size of evaluated temperature range of experimental solubility data. In this work, with the 
exception of butamben (ΔT = 15 K), the temperature ranges are fairly similar for the evaluated 
systems, and in no case exceeds 45 K.  
Conclusions 
We have shown that introducing a simple inverse temperature-dependence to the binary interaction 
parameters of the NRTL-SAC activity coefficient model leads to an improvement in the 
performance of this model for correlation of vapor-liquid as well as solid-liquid equilibrium data. 
Furthermore, the results show that, for prediction of the solubility of pharmaceutical compounds 
in organic solvents, the temperature-dependent form of NRTL-SAC results in an improvement in 
the accuracy over the original form of the model, while both models are more accurate than Pharma 
UNIFAC. For an evaluated set of pharmaceutical compounds, the accuracy of both NRTL-SAC 
models are shown to deteriorate with increasing solute molecular weight. The results stress the 
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need for more work in order to develop predictive models with accuracy sufficient for process 
design.  
Supporting information 
Experimental determination of heat capacities of solid and melt of salicylamide by differential 
scanning calorimetry, together with correlation and calculation of ∆Cp as a function of temperature. 
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